Cosmetic cross-reference Noindex: medium evidence

223705-62-2

CAS 223705-62-2

223705-62-2 (CAS 223705-62-2) is a pharmaceutical compound with 0 bioactivity targets and 8 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral / FAERS

Adverse signals

8

SOURCE IUPHAR / PharmGKB

PubMed IDs

0

SOURCE input

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

223705-62-2

CAS Number

223705-62-2

Source Match

input

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 223705-62-2 used for in pharmaceutical contexts?

223705-62-2 (CAS 223705-62-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 223705-62-2?

223705-62-2 has 8 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Acute kidney injury, Bone marrow failure, Pancytopenia, Systemic candida. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 223705-62-2 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for OXIDIZED CORN OIL with EU status "permitted".

What clinical phase is 223705-62-2 in?

No phase 1-4 clinical development badge is rendered for 223705-62-2 because the matched compound identifier rows do not contain a max-phase value.